• Profile
Close

Statins were associated with a reduced gastric cancer risk in patients with eradicated Helicobacter pylori infection: A territory-wide propensity score matched study

Cancer Epidemiology, Biomarkers & Prevention Dec 15, 2019

Cheung KS, Chan EW, Wong AYS, et al. - By performing this retrospective cohort analysis, researchers determined statin effect on gastric cancer (GC) development in H. pylori (HP)-eradicated individuals, given that people may still develop GC even following HP eradication. They used a territory-wide electronic healthcare database to recognize all adults who were prescribed clarithromycin-based triple therapy between 2003 and 2012. Cases with GC diagnosed within the first year following index date, prior GC or gastrectomy, and HP treatment failure, were excluded. Participants were observed over a median duration of 7.6 years, during which, the development of GC was reported in 169 (0.27%) of 63,605 patients at an incidence rate of 3.5 per 10,000 person-years. Findings revealed that among HP-eradicated patients, statins associated a lower GC risk in a duration- and dose-response manner.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay